跳至主要内容
临床试验/NCT05124834
NCT05124834已完成不适用

Evaluierung Der Systemgenauigkeit Des JT100 Blood Glucose Monitoring Systems Der Firma Tyson Bioresearch Inc. gemäß DIN EN ISO 15197:2015

Institut fur Diabetes Karlsburg GmbH2 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2022年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
114
试验地点
2
主要终点
Analysis of system accuracy based on DIN EN ISO 15197

研究概览

简要总结

This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197

详细描述

This study assesses the system accuracy the blood glucose monitoring systems for personal use TJ100 pursuant to ISO 15197:2015 guidelines

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients with clinical indication for blood glucose testing
  • Signed form of consent
  • Minimum age of 18 years
  • Subjects are legally competent and capable to understand character, meaning and consequences of the study

排除标准

  • Pregnancy or lactation
  • Severe acute disease (at study physician's discretion)
  • Acute or chronic diseases with inherent risk of aggravation by the procedure (at study physician's discretion)
  • Current constitution that does not allow participating in the study (e.g. hematocrit out of
  • the devices's specifications, medication known to influence blood glucose measurements; Appendix A of ISO 15197)
  • Being unable to give informed consent
  • Age younger than 18 years
  • Legally incompetent

结局指标

主要结局

Analysis of system accuracy based on DIN EN ISO 15197

时间窗: day 1

Assessment of the analytical measurement performance of the blood glucose monitor based on procedures defined in DIN EN ISO 15197

次要结局

未报告次要终点

研究者

发起方
Institut fur Diabetes Karlsburg GmbH
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthes Kenning

Dr. Eckhard Salzsieder, Director

Institut fur Diabetes Karlsburg GmbH

研究点 (2)

Loading locations...

相似试验